ReviewJournal of fluorescence2004
Current problems and potential techniques in in vivo glucose monitoring.
Review in Journal of fluorescence, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- Review
- Extended Review Concerning the Integration of Electrochemical Biosensors into Modern IoT and Wearable Devices.Biosensors · 2024Review
- Device integration of electrochemical biosensors.Nature reviews bioengineering · 2023Review
- Non-Enzymatic Detection of Glucose in Neutral Solution Using PBS-Treated Electrodeposited Copper-Nickel Electrodes.Biosensors · 2021Article
- Temperature-Corrected Fluidic Glucose Sensor Based on Microwave Resonator.Sensors (Basel, Switzerland) · 2018Article
- Microneedle-array patches loaded with dual mineralized protein/peptide particles for type 2 diabetes therapy.Nature communications · 2017Article
- Current and Emerging Technology for Continuous Glucose Monitoring.Sensors (Basel, Switzerland) · 2017Review
- In vitro evaluation of fluorescence glucose biosensor response.Sensors (Basel, Switzerland) · 2014Article
- Review
- A promising solution to enhance the sensocompatibility of biosensors in continuous glucose monitoring systems.Journal of diabetes science and technology · 2013Article
- Single-walled carbon nanotube-based near-infrared optical glucose sensors toward in vivo continuous glucose monitoring.Journal of diabetes science and technology · 2013Review
- Glucose response of near-infrared alginate-based microsphere sensors under dynamic reversible conditions.Diabetes technology & therapeutics · 2011Article
- "Smart tattoo" glucose biosensors and effect of coencapsulated anti-inflammatory agents.Journal of diabetes science and technology · 2011Article
- Ethynylated triphenylamine monoboronic acid chemosensors: experimental and theoretical studies.Journal of fluorescence · 2010Article
- Noninvasive ultrasonic glucose sensing with large pigs (approximately 200 pounds) using a lightweight cymbal transducer array and biosensors.Journal of diabetes science and technology · 2009Article
- Single walled carbon nanotubes as reporters for the optical detection of glucose.Journal of diabetes science and technology · 2009Review
- Recent advances in continuous glucose monitoring: biocompatibility of glucose sensors for implantation in subcutis.Journal of diabetes science and technology · 2007Article
- A glucose-sensing contact lens: from bench top to patient.Current opinion in biotechnology · 2005Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate in vivo monitoring of glucose concentration would be a valuable asset, particularly for management of diabetes and preterm infants during critical care. In vivo glucose monitoring devices can be divided into two categories: implanted and non-invasive. Extensive research into in vivo glucose monitoring over recent decades has not resulted in the widespread use of clinically reliable monitoring systems. For implanted devices, poor biocompatibility of the materials used for fabrication remains a major challenge, whilst progress in the commercial development of non-invasive devices is hampered by the problem of multiple interference between the detected signals and the biological components. In this review, the methods available for in in-vivo glucose monitoring are described and the associated problems are discussed.
Indexed as
Identifiers
15617259What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.